Welcome!
Cempra Pharmaceuticals, Inc. is a Biotechnology company founded in January 2006 to develop medicines to meet the increasing need for treating drug-resistant bacterial infections in the community and hospital.
Cempra is focused on capturing near-term value from market opportunities in anti-infectives. The strategy is based on the pharmaceutical and biotechnology industry experience of Cempra´s founders and advisors in the areas of drug development and anti-infectives.
Macrolides
The lead component of the company is an in-licensed pipeline of macrolides and ketolides from Optimer Pharamceuticals, with compounds at various stages of development.
